Extracellular vesicles in colorectal cancer: M2 polarization, bidirectional regulation of CAFs, metastasis, and treatment.
4 affiliations
- 1Department of Laboratory Medicine, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
- 2College of Medical Technology, Gannan Medical University, Ganzhou, China.
- 3The First School of Clinical Medicine, Gannan Medical University, Ganzhou, China.
- 4Center for Clinical Laboratories, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Abstract
Extracellular vesicles (EVs), as key mediators of intercellular communication, play a critical regulatory role in the pathogenesis and treatment of colorectal cancer (CRC). By carrying diverse bioactive molecules-including miRNAs, lncRNAs, circRNAs, and DNA-EVs influence multiple components of the tumor microenvironment (TME), such as promoting macrophage M2 polarization, reducing T and B Cell activity and proliferation, enabling evasion of natural killer (NK) cell surveillance, and regulating bidirectional fibroblast interactions in CRC. Furthermore, CRC-derived EVs can promote CRC metastasis by stimulating angiogenesis in endothelial cells, facilitating epithelial-mesenchymal transition (EMT), and promoting the formation of pre-metastatic niches. Through an analysis of the role of EVs in the pathogenesis of CRC, numerous studies have found that EVs can augment the efficacy of immunotherapy. At the same time, both mesenchymal stem cell-derived EVs and engineered EVs (such as plant-derived and microorganism-derived EVs) can play significant roles in the treatment of CRC. However, most current research remains in the in vitro and in vivo trial stages. Due to difficulties in purification and engineering, as well as inherent heterogeneity, clinical translation remains challenging; consequently, no related products have yet been brought to market. Most clinical studies remain focused on diagnostic applications, while trials for therapeutic applications are still recruiting participants. Against this backdrop, we highlight the limitations and challenges in EVs research, with the aim of providing better research directions for the clinical translation of CRC treatments.
Related
- NDFIP2 Suppresses Colorectal Cancer Metastasis Through DDX3X‐Dependent R‐Loop Remodeling and GNG13 Transcriptional Activation
- From liquid biopsy to spatial liquid biopsy: extracellular vesicles as molecular maps of cancer metastasis
- RAB7A-enriched extracellular vesicles drive early-metastasis and immune evasion in triple-negative breast cancer.
- The bidirectional role of neutrophils in the regulation of bone metabolism: a review of research progress and mechanism
- Longitudinally Monitoring Prostate Cancer Bone Metastasis and Treatment Response via Circulating Extracellular Vesicles
BibTeX
@article{wang2026extracellular,
title = {{Extracellular vesicles in colorectal cancer: M2 polarization, bidirectional regulation of CAFs, metastasis, and treatment.}},
author = {Xiaoling Wang and Zhaohua Lai and Hanlu Chen and Mei Yang and Huapei Kang and Fangsheng Wang and Junyun Huang and Yuxin Deng},
journal = {Frontiers in cell and developmental biology},
year = {2026},
month = oct,
doi = {10.3389/fcell.2026.1980961},
url = {https://europepmc.org/article/MED/42928952},
note = {CC BY},
}
RIS
TY - JOUR
TI - Extracellular vesicles in colorectal cancer: M2 polarization, bidirectional regulation of CAFs, metastasis, and treatment.
AU - Xiaoling Wang
AU - Zhaohua Lai
AU - Hanlu Chen
AU - Mei Yang
AU - Huapei Kang
AU - Fangsheng Wang
AU - Junyun Huang
AU - Yuxin Deng
PY - 2026
DA - 2026/10/12
JO - Frontiers in cell and developmental biology
DO - 10.3389/fcell.2026.1980961
UR - https://europepmc.org/article/MED/42928952
AB - Extracellular vesicles (EVs), as key mediators of intercellular communication, play a critical regulatory role in the pathogenesis and treatment of colorectal cancer (CRC). By carrying diverse bioactive molecules-including miRNAs, lncRNAs, circRNAs, and DNA-EVs influence multiple components of the tumor microenvironment (TME), such as promoting macrophage M2 polarization, reducing T and B Cell activity and proliferation, enabling evasion of natural killer (NK) cell surveillance, and regulating bidirectional fibroblast interactions in CRC. Furthermore, CRC-derived EVs can promote CRC metastasis by stimulating angiogenesis in endothelial cells, facilitating epithelial-mesenchymal transition (EMT), and promoting the formation of pre-metastatic niches. Through an analysis of the role of EVs in the pathogenesis of CRC, numerous studies have found that EVs can augment the efficacy of immunotherapy. At the same time, both mesenchymal stem cell-derived EVs and engineered EVs (such as plant-derived and microorganism-derived EVs) can play significant roles in the treatment of CRC. However, most current research remains in the in vitro and in vivo trial stages. Due to difficulties in purification and engineering, as well as inherent heterogeneity, clinical translation remains challenging; consequently, no related products have yet been brought to market. Most clinical studies remain focused on diagnostic applications, while trials for therapeutic applications are still recruiting participants. Against this backdrop, we highlight the limitations and challenges in EVs research, with the aim of providing better research directions for the clinical translation of CRC treatments.
SN - 2296-634X
ER -